メドレー
Tokyo, JP · Founded 2009 · 248 employees on LinkedIn · Public · 6 known investors
Medley develops digital healthcare platforms and services for the Japanese medical industry, including a job placement site for healthcare workers, telemedicine services, and medical information resources. The company aims to improve healthcare delivery, operational efficiency for medical institutions, and patient experience through technology solutions.
Also known as Medley Inc. · MEDLEY, INC. · 株式会社メドレー
Investors · 6
Also in the syndicate · 4
Company profile
researched Aug 2026株式会社メドレー (MEDLEY, INC.) is a Tokyo-based healthcare technology company that builds internet services for the medical and nursing-care sectors. It organizes its operations into two reported segments: a human-resources platform business and a medical platform business. Core services include ジョブメドレー, a recruitment site addressing staffing shortages in medical and nursing care; MEDLEY, an online disease/medical encyclopedia written with the cooperation of physicians; CLINICS, a cloud clinic-support and online-consultation system; 介護のほんね, a review-based nursing-home search site; and みんかい, an elderly-care home referral service. Related products cited in the company's patent disclosures include CLINICSカルテ (electronic medical record), Pharms and Dentis.
The company describes its mission as "creating the future of healthcare," pursuing "sustainable healthcare" and "healthcare people can accept," and states that it has expanded its product portfolio partly through M&A and open innovation with other companies. Recent product work is focused on AI and cloud infrastructure: an AI-native, standards-compliant cloud-native electronic medical record called MALLクラウド, an AI文書アシスト feature within CLINICS for generating medical documents, and an IR AI chat agent for investors.
The group comprises 株式会社メドレーフィナンシャルサービス, 株式会社RMキャリア, 株式会社ヘッジホッグ・メドテック, 株式会社メドレーウィズ, MEDLEY US, Inc. and Medley Philippines Inc. The company holds Japanese licenses for fee-charging employment placement, specified recruitment-information provision and worker dispatch, and has been granted patents covering symptom-based disease narrowing, integration of patient data across patient and clinic terminals, blockchain-based access control for electronic prescriptions, simplified job-application flows, unified patient-status displays and switching between online and in-person consultation formats.
Founding story
The company was established on 5 June 2009 and is led by founder and representative director/CEO 瀧口浩平. He has recounted that when he founded the business in late 2009, healthcare was perceived as legacy and heavily regulated, making it hard to attract strong engineers. In February 2015, physician 豊田剛一郎 joined as representative director (physician), and the online disease encyclopedia MEDLEY was developed under his involvement.
Business model
Medley operates two platform businesses: a human-resources platform centered on the ジョブメドレー job site for medical and nursing-care employers and workers, and a medical platform providing cloud software and online services to medical institutions, pharmacies and dental clinics (CLINICS, CLINICSカルテ, Pharms, Dentis) alongside consumer-facing information and search services such as the MEDLEY medical encyclopedia, 介護のほんね and みんかい. The company operates under Japanese paid employment-placement, recruitment-information-provision and worker-dispatch licenses.
Sources indicate recruitment-related placement/listing revenue from ジョブメドレー, described in 2015 as the base of the company's sales, and subscription/cloud software services for medical institutions; specific pricing is not detailed.
Traction
By December 2015 ジョブメドレー listed 47,055 job openings, which the CEO characterized as roughly 10% progress toward the goal of listing all medical and nursing-care jobs via direct transactions. The MEDLEY encyclopedia was reported in mid-2015 to draw more than 40,000 users on heavy days, with 220 specialist physicians proofreading disease content, over 1,100 disease entries and more than 19,000 drug information records; the site later states it is built with 873 physicians. The Nikkei BP alliance targeted 日経メディカルOnline's 510,000 members, including 130,000 physicians.
Latest developments
In 2026 the company announced development of MALLクラウド, a standards-compliant, AI-native cloud-native electronic medical record (2026-08-13); the launch of AI文書アシスト, a medical-document creation aid inside the CLINICS cloud clinic-support system (2026-08-07); and the entry of RMキャリア (formerly Recruit Medical Career) into the Medley group under its human-resources platform business (2026-08-03). It also published an IR AI chat agent answering investor questions (2026-07-30) and announced new executive officer appointments in May and August 2026.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Medley is a listed Japanese digital-health operator with services spanning healthcare recruitment, clinic cloud systems and consumer medical information. Recognition cited by the company includes ranking first in Nikkei Digital Health's 2018 "venture chosen by ventures" ranking, the 2018 Nikkei Award for Excellence in Products and Services (top prize, Nihon Keizai Shimbun award), a 2019 Good Design Best 100 award, ASPIC cloud awards in 2019 and 2020 (including the Minister for Internal Affairs and Communications prize in 2020), and third place in Forbes JAPAN's "Japan Entrepreneur Ranking 2020."
The company positions its combination of software engineers working together with physicians and other healthcare professionals as a defining trait, and has built proprietary medical databases—disease, drug, hospital and related metadata—after judging existing public medical databases to be incomplete. It also holds registered patents on several of its platform functions and links consumer information services to clinical and recruitment products across the same group.
Technology
The company combines in-house engineering with physicians and other healthcare professionals in its development teams. Its registered Japanese patents cover a symptom-based question system for narrowing likely diseases (used in the MEDLEY symptom checker), integration of patient information entered on both patient smartphones and clinic terminals, blockchain-based access control for electronic prescription data, a low-friction job-application button, a single-screen patient status view for reservations, prescription-data transformation by output destination, and post-booking switching between online and in-person consultation. Newer work is AI-oriented, including the AI-native cloud-native electronic medical record MALLクラウド and the AI文書アシスト medical-document assistant within CLINICS.
Go-to-market
Distribution is direct through the company's own web platforms for employers, medical institutions and consumers, supported by a network of domestic sales/operations offices. The company has also used capital and business alliances to expand reach, including a 2015 tie-up with Nikkei BP linking ジョブメドレー with 日経メディカルOnline, and an alliance with MRT connecting ジョブメドレー with MRT's Gaikin service. Acquisitions have added products to the group.
Medical institutions, clinics, pharmacies, dental practices and nursing-care facilities; healthcare and nursing-care professionals and job seekers; and patients, consumers and their families seeking medical information, clinic search, online consultation or elderly-care facility placement.
Geography
Headquartered at Roppongi Hills Mori Tower, Minato-ku, Tokyo, with domestic offices in Sapporo, Nagoya (two locations), Osaka (two locations), Kobe (two locations), Matsue (Tech Studio MATSUE), Hiroshima, Kochi, Nankoku, Sukumo and Fukuoka. Overseas entities are MEDLEY US, Inc. in Bellevue, Washington and Medley Philippines Inc. in Bonifacio Global City, Taguig City, and the company markets products aimed at overseas markets.
History
Founded in June 2009, Medley launched the ジョブメドレー recruitment site and, from 2015, the MEDLEY online disease encyclopedia, adding drug information in July 2015 in cooperation with Data Index and under supervising pharmacist 中澤巧. It acquired all shares of GREE subsidiary Platinum Factory, taking over the 介護のほんね nursing-facility review search site and its news site. Third-party allotment financings were completed in June and December 2015, the latter alongside a capital and business alliance with Nikkei BP. Executive hires in 2015 included former Livesense CTO 平山宗介 as head of development and ex-Recruit 寺町健 as head of the strategy execution office. The company listed on the Tokyo Stock Exchange Mothers market on 12 December 2019 (code 4480) and subsequently moved to TSE Growth. In August 2026 it announced the AI-native cloud electronic medical record MALLクラウド, the AI文書アシスト feature for CLINICS, and the addition of RMキャリア (formerly Recruit Medical Career) to the Medley group.
Risks & controversies
The company notes that the healthcare sector involves diverse stakeholders and extensive regulation, making transformation difficult, and that its products have not yet fully satisfied its stated goals of sustainable and acceptable healthcare. It operates under multiple Japanese employment-services licenses, exposing it to regulatory requirements in recruitment as well as healthcare.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlap
Companies competing with メドレー for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 22
launches, deals, and filingsMedley announced MALLクラウド, a standards-compliant cloud-native electronic medical record developed as an AI-native product.
Medley launched AI文書アシスト, a feature of the CLINICS cloud clinic-support system that assists with creating medical documents.
RM Career, formerly Recruit Medical Career, joined the Medley group under its human-resources platform business.
Medley released an AI chat agent that answers investor-relations questions.
Medley listed on the Tokyo Stock Exchange Mothers market on 12 December 2019 under securities code 4480, with an initial-price market capitalization of 35,083 million yen; the listing was later moved to TSE Growth.
Medley raised approximately 230 million yen via a third-party allotment to Nikkei BP, existing shareholder East Ventures and individual investor Ken Honda (FreakOut CEO), to fund development of new services from the Nikkei BP alliance.
Capital and business alliance with Nikkei BP to strengthen integration between 日経メディカルOnline and ジョブメドレー and jointly plan new services for its 510,000 members, including 130,000 physicians.
Former Livesense CTO 平山宗介 became head of development at Medley; ex-Recruit 寺町健 was also named head of the strategy execution office.
MEDLEY began publishing drug information, including latest package inserts, in cooperation with Data Index, with more than 19,000 drug records linked to over 1,100 disease entries; pharmacist 中澤巧 was appointed supervising pharmacist.
Medley announced a third-party allotment of shares totaling 300 million yen, subscribed by Mitsui Sumitomo Insurance Venture Capital, MRT, GREE and individual shareholders, accompanied by a business alliance with MRT.
Business alliance with MRT linking Medley's ジョブメドレー recruitment site with MRT's Gaikin external-work placement service and jointly developing new services.
Physician 豊田剛一郎 joined Medley as representative director (physician), alongside development of the MEDLEY online disease information service.
Medley acquired all shares of Platinum Factory, a wholly owned GREE subsidiary, taking over the nursing-facility review search site 介護のほんね and the news site 介護のほんねニュース.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- メドレーmedley.jp · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does メドレー do?
- Japanese healthcare technology company operating job-matching, clinic cloud software and medical information platforms.
- Who are メドレー's investors?
- メドレー's investors include Global Brain, Globis Capital Partners.
- Where is メドレー headquartered?
- メドレー is headquartered in Tokyo, JP.